Bellicum Pharmaceuticals, Inc.

BLCMNASDAQHealthcare

$0.07

$-0.01(-6.68%)

Market Cap$778326

P/E Ratio—

52W High$1.31

52W Low$0.06

Avg Volume28K

Open$0.08

Beta1.38

Forecast Market Cap PE Ratio

Bellicum Pharmaceuticals, Inc.（BLCM）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

blcm · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2025年4月12日

分析师评级与共识

基于过去 3 个月内 9 位华尔街分析师

Buy

9 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 9 · 买入占比: 88.9%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $0.07

Bellicum Pharmaceuticals, Inc.（BLCM）的分析师共识为 Buy，基于过去 3 个月内 9 位华尔街分析师的评级。BLCM 的 12 个月平均目标价为 $0.00，相对当前价 $0.07 代表 +0.0% 的潜在上行空间。

短期股价预测

Low Activity

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-10	$0.07	↓ 2.73%	$0.07	$0.08

1-day model range: $0.07–$0.08. Peak: $0.08 (-2.73%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

🚫

Insufficient Trading Activity — Sentiment Signals Disabled

This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.

RSI (14)38.6

MACDBEARISH

Moving Averages · BLCM · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$0.08SELL

MA 10$0.08SELL

MA 20$0.09SELL

MA 50$0.11SELL

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $BLCM · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$0.08SELL

EMA 10$0.08SELL

EMA 20$0.09SELL

EMA 50$0.12SELL

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $BLCM · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2022-02-16	Ladenburg Thalmann	Maintains	Buy→Buy
2020-11-25	Wells Fargo	Downgrade ↓	Outperform→Perform
2020-11-25	Raymond James	Maintains	Outperform→Outperform
2020-11-25	Citigroup	Maintains	Neutral→Neutral
2020-11-25	Wells Fargo	Upgrade ↑	Market Perform→Outperform
2020-11-25	Citigroup	Upgrade ↑	Neutral→Buy
2020-11-25	Jefferies	Maintains	Buy→Buy
2020-10-30	Wells Fargo	Downgrade ↓	Overweight→Equal Weight
2020-10-29	Wells Fargo	Downgrade ↓	Overweight→Equal Weight
2020-03-13	Raymond James	Maintains	Outperform→Outperform

Ladenburg Thalmann2022-02-16

Maintains

Buy→Buy

Wells Fargo2020-11-25

Downgrade ↓

Outperform→Perform

Raymond James2020-11-25

Maintains

Outperform→Outperform

Citigroup2020-11-25

Maintains

Neutral→Neutral

Wells Fargo2020-11-25

Upgrade ↑

Market Perform→Outperform

Citigroup2020-11-25

Upgrade ↑

Neutral→Buy

Jefferies2020-11-25

Maintains

Buy→Buy

Wells Fargo2020-10-30

Downgrade ↓

Overweight→Equal Weight

Wells Fargo2020-10-29

Downgrade ↓

Overweight→Equal Weight

Raymond James2020-03-13

Maintains

Outperform→Outperform

Wall Street analysts have recently issued updated ratings on Bellicum Pharmaceuticals, Inc. (BLCM) stock. Of the recent 39 rating actions, 6 were upgrades and 6 were downgrades. 9 analysts currently cover BLCM.

分析师推荐趋势

Buy ratings2 → 1↓ 1

Hold ratings0 → 0

Sell ratings0 → 0

BLCM analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$1M

↑ 9900.0% YoY

Revenue Next Year

$2M

↑ 50.0% YoY

EPS This Year

$-4.19

EPS Next Year

$-1.07

↓ 74.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BLCM EPS of $-4.19 for the current fiscal year, based on estimates from 0 analysts. The BLCM revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

BLCM 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。BLCM 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。

BLCM 的短期预测（明日）为 $0.07（-2.73%）。

Bellicum Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 BLCM。BLCM 在 2027 年的整体展望偏积极，在覆盖分析师中约 89% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

BLCM 预测 · 8 个问题

根据 9 位华尔街分析师，BLCM 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.07，隐含约 +0.0% 的上行空间。

BLCM 目标价BLCM 分析师目标价BLCM 12个月目标价目标价 BLCM

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.